Literature DB >> 33899165

Authors' Reply to Suhas et al.: Comment on: "Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation".

Georgios Schoretsanitis1,2, Maxim Kuzin3, John M Kane4,5,6, Christoph Hiemke7, Michael Paulzen8,9,10, Ekkehard Haen11,12.   

Abstract

Entities:  

Year:  2021        PMID： 33899165     DOI： 10.1007/s40262-021-01022-0

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  1 in total

1.  Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

Authors:  C Hiemke; N Bergemann; H W Clement; A Conca; J Deckert; K Domschke; G Eckermann; K Egberts; M Gerlach; C Greiner; G Gründer; E Haen; U Havemann-Reinecke; G Hefner; R Helmer; G Janssen; E Jaquenoud; G Laux; T Messer; R Mössner; M J Müller; M Paulzen; B Pfuhlmann; P Riederer; A Saria; B Schoppek; G Schoretsanitis; M Schwarz; M Silva Gracia; B Stegmann; W Steimer; J C Stingl; M Uhr; S Ulrich; S Unterecker; R Waschgler; G Zernig; G Zurek; P Baumann
Journal:  Pharmacopsychiatry       Date:  2018-02-01       Impact factor: 5.788
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.